Not dead.
Under verification.

Verification pipeline

• Clinical Trials

  {"nct_id":"NCT05447078","title":"Spirulina Oral Supplement for Enhancing Host Resilience to Virus Infection","sponsor":"University of Mississippi Medical Center","phase":"PHASE3","status":"COMPLETED","primary_outcome":"Natural Killer cell (NK)-mediated cytotoxicity — NK cell-mediated cytotoxicity is characterized by cytolysis of a CFSE-labeled target cell (K562) by effector cells (NK cells). Labeled K562 are cultured with NK cells for a period of time, then all cells labeled with a live-dead stain, 7-AAD. The cytolytic activity is expressed as the percent dead K562.\n\nDifferences in cytolytic activity (% dead K562) from baseline to 20 weeks.","lead_sponsor_class":"OTHER","completion_date":"2025-12-08"}

  224

  19h ago

• Yield Curve

  {"series_id":"DGS2","observation_date":"2026-08-25","value":4.17,"prior_value":4.24,"delta":-0.07000000000000028}

  862

  23h ago

• SEC 13F (snapshots)

  {"filer_cik":"0002134841","filer_name":"First Nebraska Trust Co (CIK 0002134841)","form":"13F-HR","file_date":"2026-08-26","period_of_report":null,"accession":"0002134841-26-000133","cusip":"14149Y108","ticker":"CAH","name_of_issuer":"CARDINAL HEALTH INC","title_of_class":"COM","value_raw":1184976,"shares":20800,"share_type":"SH"}

  193,391

  24h ago

• SEC Insider Filing

  {"issuer_cik":"0001339688","issuer_ticker":"LCGMF","reporting_person":"PAREDES MARIA MILAGROS (CIK 0002142576)","form":"4","file_date":"2026-08-26","accession":"0002142576-26-000001"}

  63,088

  24h ago